BioMarin Pharmaceutical, Inc. (BMRN)
59.22
-0.82
(-1.37%)
USD |
NASDAQ |
Dec 30, 13:51
BioMarin Pharmaceutical Total Liabilities (Quarterly): 1.558B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| Gilead Sciences, Inc. | 37.08B |
| Merck & Co., Inc. | 77.64B |
| AbbVie, Inc. | 136.50B |
| Bristol Myers Squibb Co. | 78.29B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.615B |
| Shareholders Equity (Quarterly) | 6.057B |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 4.828 |
| Net Debt Paydown Yield | 0.94% |